Search filters

List of works by Rebecca E Parker

Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation.

scientific article

Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells

scientific article published on 20 March 2018

Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology

scientific article published on 20 September 2019

Highly selective MERTK inhibitors achieved by a single methyl group

article

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms

article

MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents

scientific article published on 09 August 2018

MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancers Expressing Wild-type EGFR Family Members

scientific article published on 07 September 2018

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity

scientific article published on 2 November 2018

Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms

scientific article

The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo

scientific article published on 29 January 2021

Paulina is supported by:

About Paulina

Help